ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,047Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 198

$824K Total Retail Price of All Prescriptions

Rank: 18 out of 198

724 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 724 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 724 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 13,844 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 769 701 1 1
SIMVASTATIN 532 507 2 2
FUROSEMIDE 423 413 3 5
AMLODIPINE BESYLATE 419 419 4 4
ATORVASTATIN CALCIUM 419 386 4 12
WARFARIN SODIUM 409 390 6 7
PRAVASTATIN SODIUM 304 277 7 19
BENAZEPRIL HCL 302 287 8 45
LISINOPRIL 296 290 9 6
HYDROCODONE-ACETAMINOPHEN 293 255 S3 10 8
OMEPRAZOLE 290 279 11 3
METOPROLOL SUCCINATE 282 264 12 11
METFORMIN HCL 253 234 13 13
METOPROLOL TARTRATE 195 190 14 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 177 165 15 38
PANTOPRAZOLE SODIUM 158 123 16 31
ATENOLOL 158 157 16 17
ZOLPIDEM TARTRATE 152 133 18 22
SYNTHROID 150 145 19 36
LOSARTAN POTASSIUM 147 147 20 18
POTASSIUM CHLORIDE 147 146 20 9
SERTRALINE HCL 146 139 22 25
GABAPENTIN 142 110 23 14
TAMSULOSIN HCL 138 133 24 27
LOSARTAN-HYDROCHLOROTHIAZIDE 130 125 25 49
MIRTAZAPINE 126 126 26 44
DONEPEZIL HCL 123 123 27 28
CRESTOR 121 118 28 26
PREDNISONE 121 114 28 29
HYDROCHLOROTHIAZIDE 120 104 30 16
TRAMADOL HCL 118 102 31 15
CARVEDILOL 110 110 32 24
MELOXICAM 109 108 33 30
CITALOPRAM HBR 109 92 33 20
NEXIUM 103 100 35 40
BENAZEPRIL-HYDROCHLOROTHIAZIDE 98 81 36 155
DIOVAN 95 94 37 34
GLIPIZIDE 94 94 38 62
ESCITALOPRAM OXALATE 93 85 39 53
LEVOFLOXACIN 92 78 40 81
CLOPIDOGREL 91 80 41 42
LANTUS 91 91 41 46
ALENDRONATE SODIUM 90 77 43 21
PEN NEEDLE 89 88 44 114
TRAZODONE HCL 88 80 45 50
TRIAMTERENE-HCTZ 88 76 45 32
BENICAR 86 81 47 100
AZITHROMYCIN 81 71 48 56
PREMARIN 78 75 R 49 101
GLYBURIDE-METFORMIN HCL 73 59 R 50 173
PLAVIX 73 64 50 66
NAMENDA 72 72 52 33
LIPITOR 68 68 53 116
AMITRIPTYLINE HCL 67 50 R 54 69
FLUTICASONE PROPIONATE 66 58 55 39
AGGRENOX 63 63 56 164
LANTUS SOLOSTAR 61 60 57 85
ADVAIR DISKUS 60 60 58 47
NASONEX 59 55 59 189
PROAIR HFA 57 41 60 80
VERAPAMIL ER 56 56 61 117
SPIRONOLACTONE 55 47 62 37
ALLOPURINOL 55 47 62 23
WELCHOL 55 40 62 139
SYMBICORT 53 52 65 150
HUMALOG 53 52 65 128
TORSEMIDE 52 47 67 75
BENICAR HCT 52 40 67 175
VESICARE 52 52 67 77
FAMOTIDINE 51 51 70 57
NIASPAN 51 37 70 138
VENLAFAXINE HCL ER 50 49 72 84
AMOX TR-POTASSIUM CLAVULANATE 50 43 72 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.